BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 22233502)

  • 1. New insights into the mechanisms of the vasorelaxant effects of apocynin in rat thoracic aorta.
    Senejoux F; Girard-Thernier C; Berthelot A; Bévalot F; Demougeot C
    Fundam Clin Pharmacol; 2013 Jun; 27(3):262-70. PubMed ID: 22233502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
    Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
    J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant and hypotensive effects of a hydroalcoholic extract from the fruits of Nitraria sibirica Pall. (Nitrariaceae).
    Senejoux F; Girard C; Aisa HA; Bakri M; Kerram P; Berthelot A; Bévalot F; Demougeot C
    J Ethnopharmacol; 2012 Jun; 141(2):629-34. PubMed ID: 21864668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator and antihypertensive effects of a novel N-acylhydrazone derivative mediated by the inhibition of L-type Ca²⁺ channels.
    Pereira SL; Kummerle AE; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Fundam Clin Pharmacol; 2014 Feb; 28(1):29-41. PubMed ID: 22958093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the mechanisms underlying the vasorelaxant action of kaurenoic acid in the isolated rat aorta.
    Tirapelli CR; Ambrosio SR; da Costa FB; Coutinho ST; de Oliveira DC; de Oliveira AM
    Eur J Pharmacol; 2004 May; 492(2-3):233-41. PubMed ID: 15178370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-dependent and -independent vasorelaxation induced by CIJ-3-2F, a novel benzyl-furoquinoline with antiarrhythmic action, in rat aorta.
    Chang GJ; Lin TP; Ko YS; Lin MS
    Life Sci; 2010 Jun; 86(23-24):869-79. PubMed ID: 20388521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory activity and antihypertensive profile mediated by inhibition of phosphodiesterase type 1 induced by a novel sulfonamide compound.
    Pontes LB; Antunes F; Sudo RT; Raimundo JM; Lima LM; Barreiro EJ; Zapata-Sudo G
    Fundam Clin Pharmacol; 2012 Dec; 26(6):690-700. PubMed ID: 22066694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct effect of levobupivacaine in isolated rat aorta involves lipoxygenase pathway activation and endothelial nitric oxide release.
    Choi YS; Jeong YS; Ok SH; Shin IW; Lee SH; Park JY; Hwang EM; Hah YS; Sohn JT
    Anesth Analg; 2010 Feb; 110(2):341-9. PubMed ID: 19955508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium nitric oxide-independent vasorelaxant effects of the aqueous extract from Stephania abyssinica on the isolated rat thoracic aorta.
    Nguelefack TB; Fodem C; Nguelefack-Mbuyo EP; Nyadjeu P; Wansi SL; Watcho P; Kamanyi A
    J Complement Integr Med; 2015 Mar; 12(1):15-21. PubMed ID: 25390028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxant effects of Shunaoxin pill are mediated by NO/cGMP pathway, HO/CO pathway and calcium channel blockade in isolated rat thoracic aorta.
    Huo L; Zhang J; Qu Z; Chen H; Li Y; Gao W
    J Ethnopharmacol; 2015 Sep; 173():352-60. PubMed ID: 26239154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation.
    Ng CF; Koon CM; Cheung DW; Lam MY; Leung PC; Lau CB; Fung KP
    J Ethnopharmacol; 2011 Oct; 137(3):1366-72. PubMed ID: 21855622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasorelaxing and antihypertensive effects of 7,8-dihydroxyflavone.
    Huai R; Han X; Wang B; Li C; Niu Y; Li R; Qu Z
    Am J Hypertens; 2014 May; 27(5):750-60. PubMed ID: 24317273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasorelaxant effect of formononetin in the rat thoracic aorta and its mechanisms.
    Zhao Y; Chen BN; Wang SB; Wang SH; Du GH
    J Asian Nat Prod Res; 2012; 14(1):46-54. PubMed ID: 22263593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
    Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
    Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional study of the [Ca2+]i signaling pathway in aortas of L-NAME-hypertensive rats.
    de Campos Grifoni S; Bendhack LM
    Pharmacology; 2004 Mar; 70(3):160-8. PubMed ID: 14752236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine induces rat aorta relaxation by nitric oxide-dependent and -independent mechanisms.
    Molin JC; Bendhack LM
    Vascul Pharmacol; 2004 Aug; 42(1):1-6. PubMed ID: 15664881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive and vasorelaxant effect of Diapocynin in normotensive rats.
    Potje SR; Troiano JA; Graton ME; Ximenes VF; Nakamune ACMS; Antoniali C
    Free Radic Biol Med; 2017 May; 106():148-157. PubMed ID: 28192231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasorelaxant and antihypertensive effects of methanolic fraction of the essential oil of Alpinia zerumbet.
    da Cunha GH; de Moraes MO; Fechine FV; Frota Bezerra FA; Silveira ER; Canuto KM; de Moraes ME
    Vascul Pharmacol; 2013; 58(5-6):337-45. PubMed ID: 23603277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.